CARDINAL HEALTH INC
No SEC Form 4 filings for $CAH in the last 30 days.
HighTower Advisors LLC increased its Cardinal Health (NYSE:CAH) stake by 7.8% in Q4, buying 5,238 shares to hold 72,152 shares, worth $14.827 million as of its latest SEC filing, according to HoldingsChannel. The article also cites other institutional buying/selling. Cardinal Health reported Q1 EPS of $3.17 vs $2.79 expected, and set FY2026 guidance of 10.70–10.80 EPS.
Cardinal Health Inc. has declared a higher quarterly dividend, drawing investor attention to its role in the US healthcare distribution system. The company, a major distributor of pharmaceuticals and medical products, plays a critical role in the healthcare supply chain despite operating with relatively low margins. Its performance is influenced by demand for prescription drugs, the mix of branded and generic medicines, and hospital capital budgets.
This article reviews the Q1 performance of Cardinal Health (NYSE:CAH) and other key players in the healthcare providers & services sector. It highlights Cardinal Health's steady performance, agilon health's strong Q1 as the sector's top performer, and Option Care Health's and Brookdale's weaker results. The piece also touches on shifts in market investor sentiment from AI concerns to geopolitical risks.
